The recent identification of a core set of neuro-developmental transcription factors (POU3F2, SOX2, SALL2, and OLIG2) that are sufficient to fully reprogram differentiated GBM cells to ‘‘induced’’ tumor promoting cells, puts forth the possibility of bidirectional plasticity through epigenetic reprogramming [72]. This evidence concerns the gene OLIG2 and glioblastoma.